Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6095-6104

  Brys, Lea ^a   Beschin, Alain ^a   Raes, Geert ^a   Ghassabeh, Gholamreza Hassanzadeh ^a   Noël, Wim ^a   Brandt, Jef ^b   Brombacher, Frank ^c   De Baetselier, Patrick ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARGINASE; CD11B ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN FIZZ1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; HELMINTHIASIS; IMMUNE DEFICIENCY; IMMUNOREGULATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPPRESSOR CELL; TAENIA CRASSICEPS; TAENIASIS;

EID: 18644370173     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6095     Document Type: Article

References (69)

1. Strober, S. 1984. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2: 219-237.
2. Maier, T., J. H. Holda, and H. N. Claman. 1989. Natural suppressor cells. Prog. Clin. Biol. Res. 288: 235-244.
3. Pelaez, B., J. A. Campillo, J. A. Lopez-Asenjo, and J. L. Subiza. 2001. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166: 6608-6615.
4. Serafini, P., C. De Santo, I. Mango, S. Cingarlini, L. Dolcetti, G. Gallina, P. Zanovello, and V. Bronte. 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53: 64-72.
5. Ferret-Bernard, S., P. Sai, and J. M. Bach. 2004. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-γ from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Immunol. Lett. 91: 221-217.
6. + T cells. Blood 96: 3838-3846.
7. + cells. J. Immunol. 161: 5313-5320.
8. + T cell proliferation via an IFN-γ and nitric oxide-dependent mechanism. J. Immunol. 167: 4293-4302.
9. Cauley, L. S., E. E. Miller, M. Yen, and S. L. Swain. 2000. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-γ. J. Immunol. 165: 6056-6066.
10. + cells: a potential mechanism for immune polarization, in helminth infections. J. Immunol. 167: 5294-5303.
11. + cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 95: 212-220.
12. + T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol. 162: 5728-5737.
13. Apolloni, E., V. Bronte, A. Mazzoni, P. Serafini, A. Cabrelle, D. M. Segal, H. A. Young, and P. Zanovello. 2000. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 165: 6723-6730.
14. Liu, Y., J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof. 2003. Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cells. J. Immunol. 170: 5064-5074.
15. + myeloid cells. J. Immunol. 166: 5398-5406.
16. + cells in the development of antitumor immunity. Cancer Res. 64: 1130-1139.
17. + myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169: 3180-3190.
18. Mordue, D. G., and L. D. Sibley. 2003. A novel population of Gr-1 +-activated macrophages induced during acute toxoplasmosis. J. Leukocyte Biol. 74: 1015-1025.
19. +immature myeloid suppressor cells. Int. Immunol. 14: 1125-1134.
20. Bronte, V., P. Serafini, A. Mazzoni, D. M. Segal, and P. Zanovello. 2003. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 24: 302-306.
21. Terabe, M., and J. A. Berzofsky, 2004. Immunoregulatory T cells in tumor immunity. Curr. Opin. Immunol. 16: 157-362.
22. Terabe, M., S. Matsui, J. M. Park, M. Mamura, N. Noben-Trauth, D. D. Donaldson, W. Chen, S. M. Wahl, S. Ledbetter, B. Pratt, et al. 2003. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198: 1741-1752.
23. + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172: 989-999.
24. + T cells. Eur. J. Immunol. 30: 1127-1135.
25. Loke, P., A. S. MacDonald, A. Robb, R. M. Maizels, and J. E. Allen. 2000. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30: 2669-2678.
26. MacDonald, A. S., R. M. Maizels, R. A. Lawrence, I. Dransfield, and J. E. Allen. 1998. Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites. J. Immunol. 160: 1304-1312.
27. Rodriguez-Sosa, M., A. R. Satoskar, R. Calderon, L. Gomez-Garcia, R. Saavedra, R. Bojalil, and L. I. Terrazas. 2002. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect. Immun. 70: 3656-3664.
28. Rodriguez-Sosa, M., L. E. Rosas, J. R. David, R. Bojalil, A. R. Satoskar, and L. I. Terrazas. 2003. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect. Immun. 71: 1247-1254.
29. Marshall, M. A., D. Jankovic, V. E. Maher, A. Sher, and J. A. Berzofsky. 2001. Mice infected with Schistosoma mansoni develop a novel non-T-lymphocyte suppressor population which inhibits virus-specific CTL induction via a soluble factor. Microbes Infect. 3: 1051-1061.
30. Noben-Trauth, N., G. Kohler, K. Burki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5: 487-491.
31. Mohrs, M., B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4- and IL-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162: 7302-7308.
32. Bronte, V., P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutler, et al. 2003. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170: 270-278.
33. Taylor, P. R., G. D. Brown, A. B. Geldhof, L. Martinez-Pomares, and S. Gordon. 2003. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 33: 2090-2097.
34. Ramalingam, T., B. Rajan, J. Lee, and T. V. Rajan. 2003. Kinetics of cellular responses to intraperitoneal Brugia pahangi infections in normal and immunodeficient mice. Infect. Immun. 71: 4361-4367.
35. Rodriguez-Sosa, M., J. R. David, R. Bojalil, A. R. Satoskar, and L. I. Terrazas. 2002. Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J. Immunol. 168: 3135-3139.
36. Toenjes, S. A., and R. E. Kuhn. 2003. The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type. Parasitol. Res. 89: 407-413.
37. Raes, G., L. Brys, B. K. Dahal, J. Brandt, J. Grooten, F. Brombacher, G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, et al. 2005. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukocyte Biol. 77: 321-327.
38. Loke, P., M. G. Nair, J. Parkinson, D. Guiliano, M. Blaxter, and J. E. Allen. 2002. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3: 7.
39. Raes, G., P. De Baetselier, W. Noel, A. Beschin, F. Brombacher, and G. Hassanzadeh Gh. 2002. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukocyte Biol. 71: 597-602.
40. Sciutto, E., G. Fragoso, M. Baca, V. De la Cruz, L. Lemus, and E. Lamoyi. 1995. Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infect. Immun. 63: 2277-2281.
41. Spolski, R. J., M. A. Alexander-Miller, and R. E. Kuhn. 2002. Suppressed cytotoxic T lymphocyte responses in experimental cysticercosis. Vet. Parasitol. 106: 325-330.
42. Spolski, R. J., J. Corson, P. G. Thomas, and R. E. Kuhn. 2000. Parasite-secreted products regulate the host response to larval Taenia crassiceps. Parasite Immunol. 22: 297-305.
43. Yang, X. Y., L. H. Wang, K. Mihalic, W. Xiao, T. Chen, P. Li, L. M. Wahl, and W. L. Farrar. 2002. Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor γ activated by macrophage-derived 12/15-lipoxygenase ligands. J. Biol. Chem. 277: 3973-3978.
44. Na, H. K., and Y. J. Surh. 2003. Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem. Pharmacol. 66: 1381-1391.
45. Sciutto, E., G. Fragoso, A. Fleury, J. P. Laclette, J. Sotelo, A. Aluja, L. Vargas, and C. Larralde. 2000. Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infecs. 2: 1875-1890.
46. Terrazas, L. I., M. Cruz, M. Rodriguez-Sosa, R. Bojalil, F. Garcia-Tamayo, and C. Larralde. 1999. Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol. Res. 85: 135-141.
47. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533-6544.
48. Kullberg, M. C., E. J. Pearce, S. E. Hieny, A. Sher, and J. A. Berzofsky. 1992. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J. Immunol. 148: 3264-3270.
49. Actor, J. K., M. A. Marshall, I. A. Eltoum, R. M. Buller, J. A. Berzofsky, and A. Sher. 1994. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur. J. Immunol. 24: 3050-3056.
50. Kamal, S., M. Madwar, L. Bianchi, A. E. Tawil, R. Fawzy, T. Peters, and J. W. Rasenack. 2000. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20: 281-289.
51. Sabin, E. A., M. I. Araujo, E. M. Carvalho, and E. J. Pearce. 1996. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173: 269-272.
52. + splenocytes undergo apoptosis during an experimental murine infection with Taenia crassiceps. Parasitol. Res. 90: 157-163.
53. Freire-de-Lima, C. G., D. O. Nascimento, M. B. Soares, P. T. Bozza, H. C. Castro-Faria-Neto, F. G. de Mello, G. A. DosReis, and M. F. Lopes. 2000. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403: 199-203.
54. Ribetro-Gomes, F. L., A. C. Otero, N. A. Gomes, M. C. Moniz-De-Souza, L. Cysne-Finkelstein, A. C. Arnholdt, V. L. Calich, S. G. Coutinho, M. F. Lopes, and G. A. DosReis. 2004. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 172: 4454-4462.
55. Tawill, S., L. Le Goff, F. Ali, M. Blaxter, and J. E. Allen. 2004. Both free-living and parasitic nematodes induce a characteristic Th2 response that is dependent on the presence of intact glycans. Infect. Immun. 72: 398-407.
56. Stempin, C., L. Giordanengo, S. Gea, and F. Cerban. 2002. Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. J. Leukocyte Biol. 72: 727-734.
57. Giordanengo, L., N. Guinazu, C. Stempin, R. Fretes, F. Cerban, and S. Gea. 2002. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 32: 1003-1011.
58. Stempin, C. C., T. B. Tanos, O. A. Coso, and F. M. Cerban. 2004. Arginase induction promotes Trypanosoma cruzi intracellular replication in Cruzipain-treated J774 cells through the activation of multiple signaling pathways. Eur. J. Immunol. 34: 200-209.
59. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. 2002, Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168: 689-695.
60. + carrier hCAT-2B. Nitric Oxide 1: 65-73.
61. Jacobsen, S. E., C. Okkenhaug, O. P. Veiby, D. Caput, P. Ferrara, and A. Minty. 1994. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp. Med. 180: 75-82.
62. Snoeck, H. W., M. Lenjou, G. Nys, F. Lardon, M. E. Peetermans, D. R. Van Bockstaele, A. Moulijn, L. Haenen, and Z. N. Berneman. 1996. Interleukin 4 and interferon γ costimulate the expansion of early human myeloid colony-forming cells. Proposal of a model for the regulation of myelopoiesis by interleukin 4 and interferon γ and its integration with the regulation of the immune response. Leukemia 10: 117-122.
63. Voehringer, D., K. Shinkai, and R. M. Locksley. 2004. Type 2 immunity reflects orchestrated recruitment of cells committed to 1L-4 production. Immunity 20: 267-277.
64. La Flamme, A. C., E. A. Patton, B. Bauman, and E. J. Pearce. 2001. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J. Immunol. 166: 1903-1911.
65. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
66. Nencioni, A., S. Wesselborg, and P. Brossart. 2003. Role of peroxisome proliferator-activated receptor γ and its ligands in the control of immune responses. Crit. Rev. Immunol. 23: 1-13.
67. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400: 378-382.
68. Yang, X. Y., L. H. Wang, T. Chen, D. R. Hodge, J. H. Resau, L. DaSilva, and W. L. Farrar. 2000. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor γ (PPARγ) agonists. PPARγ co-association with transcription factor NFAT. J. Biol. Chem. 275: 4541-4544.
69. Lovat, P. E., S. Oliverio, M. Ranalli, M. Corazzari, C. Rodolfo, F. Beraassola, K. Aughton, M. Maccarrone, Q. D. Hewson, A. D. Pearson, et al. 2002. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res. 62: 5158-5167.